Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ovarian Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ovarian Cancer
    TopAbstracts in Ovarian Cancer 11/18/2009 - (DGNews)
    TopAbstracts in Ovarian Cancer 10/21/2009 - (DGNews)
    Neoadjuvant Chemotherapy Confers Important Benefits in Advanced Ovarian Cancer: Presented at ACS - (DGDispatch)
    Dose-Dense Chemotherapy Improves Survival in Advanced Ovarian Cancer - (DGNews)
    TopAbstracts in Ovarian Cancer 09/23/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Ovarian Cancer
  • Current Therapeutic Options and Clinical Issues in Recurrent Ovarian Cancer: Where Do We Stand?
  • Ovarian Cancer: Designed for the Primary Care Physician

    Webcasts/CME archive

     Recent cases - Ovarian Cancer
      Leser-Trelat Sign Presenting in a Patient with Ovarian Cancer: A Case Report
      Large Family with Both Parents Affected by Distinct BRCA1 Mutations: Implications for Genetic Testing
      Primary Hepatic Embryonal Sarcoma Masquerading as Metastatic Ovarian Cancer
      Choroidal Eye Metastases from (Recurrent) Primary Peritoneal Carcinoma: Case Report and Review of the Literature
      A Case of Meigs Syndrome Mimicking Metastatic Breast Carcinoma

      Cases archive
        




      my personal edition > ovarian cancer > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Evaluating Connection Between Ovulation and Ovarian Cancer Risk

      A DGReview of :"Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States)."
      Cancer Causes and Control

      12/17/2002
      By Anne MacLennan


      Episodes of anovulation prompted by menstrual disturbances should be evaluated separately from those resulting from pregnancy or oral contraceptive, say researchers in the United States.

      Obtaining additional details on menstrual factors that affect lifetime ovulatory cycles (LOC), particularly data on missed or irregular cycles, provides critical information on women's ovarian cancer risk, these investigators from Duke University Medical Center, Durham, North Carolina, have found.

      In this population-based study of ovarian cancer, Dr P G Moorman and colleagues from Duke's Cancer Prevention, Detection, and Control Research Program, Department of Community and Family Medicine compared the standard method for calculating LOC with a second method in which more detailed information on menstrual characteristics is obtained.

      To determine if the additional data results in stronger links with ovarian cancer, the researchers reviewed data from 232 cases and 242 controls and used unconditional logistic regression to estimate odds ratios for ovarian cancer by number of LOC.

      Average number of LOC was 29 fewer for the method in which more detailed menstrual cycle information was obtained as compared with the standard method (p < 0.0001). This difference was largely the effect of the inclusion in the second method of information about episodes missed/irregular periods.

      Links between LOC and ovarian cancer were weaker for the second method than the standard method. Further analyses indicated a reduced number of ovulatory cycles as result of menstrual irregularity was linked with increased ovarian cancer risk. This was on contrast to the protective effects observed for fewer ovulatory cycles due to pregnancy or oral contraceptive use.
      Cancer Causes Control 2002 Nov;13(9):807-11. "Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States)."

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send